Fortress Biotech (FBIO) Capital Expenditures Growth (5y) (2015 - 2024)
Powered by 
Analysis
Fortress Biotech (FBIO) Capital Expenditures Growth (5y) (2015 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -36.79% |
| Jun 30, 2024 | 16.32% |
| Dec 31, 2023 | -39.27% |
| Sep 30, 2023 | -78.41% |
| Jun 30, 2023 | -66.60% |
| Mar 31, 2023 | -52.76% |
| Dec 31, 2022 | 17.70% |
| Sep 30, 2022 | 12.45% |
| Jun 30, 2022 | 9.73% |
| Mar 31, 2022 | 38.64% |
| Dec 31, 2021 | 26.09% |
| Sep 30, 2021 | -20.55% |
| Jun 30, 2021 | -4.40% |
| Mar 31, 2021 | -24.98% |
| Dec 31, 2020 | 29.86% |
| Sep 30, 2020 | -68.49% |
| Jun 30, 2020 | 89.87% |
| Dec 31, 2018 | 60.63% |
| Sep 30, 2018 | 96.05% |
| Jun 30, 2018 | 70.89% |